☆ 4.7 Letter

Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance-Letter

CLINICAL CANCER RESEARCH (2019)

Journal

CLINICAL CANCER RESEARCH

Volume 25, Issue 10, Pages 3192-3192

Publisher

AMER ASSOC CANCER RESEARCH

DOI: 10.1158/1078-0432.CCR-19-0164

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Editorial Material Oncology

Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers response

Rivka R. Colen, Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey, Priyadarshini Mamindla, Pascal O. Zinn, Chaan Ng, Raghu Vikram, Spyridon Bakas, Christine B. Peterson, Jordi Rodon Ahnert, Vivek Subbiah, Daniel D. Karp, Bettzy Stephen, Joud Hajjar, Aung Naing

Summary: In our study, we focused on predicting immunotherapy response in patients with rare cancers using radiomics analysis. By selecting appropriate feature selection and classifier methods, avoiding overfitting, checking for multicollinearity among features, and performing 10-fold cross-validation, we achieved effective predictive performance for our radiomics models.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Editorial Material Oncology

Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare

Mateus Trinconi Cunha, Vinicius Jardim Carvalho, Rafael Maffei Loureiro, Carlos Eduardo Brantis-de-Carvalho, Murilo Bicudo Cintra, Gilberto de Castro Junior

Summary: The commentary highlights potential issues with predictor selection, cross-validation method, and lack of final testing in a research article, which may lead to overfitting and overestimation of performance metrics.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Oncology

Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer

Byung Min Lee, Yeona Cho, Jun Won Kim, Sung Gwe Ahn, Jee Hung Kim, Hei Cheul Jeung, Joon Jeong, Ik Jae Lee

Summary: This study investigated the association between skeletal muscle loss and response to neoadjuvant chemotherapy in breast cancer patients. The results showed that skeletal muscle loss and cancer stage were significantly associated with poor response to neoadjuvant chemotherapy in locally advanced breast cancer patients. Accurately measuring muscle loss and delaying its progression through interventions may improve the response to neoadjuvant chemotherapy and overall clinical outcomes.

CANCERS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product

Martin Beliveau, Deborah Anderson, Doug Barker, Shantha Kodihalli, Emilie Simard, Christine Hall, Jason S. Richardson

Summary: Botulism antitoxin heptavalent (BAT) product, derived from horses immunized with specific serotypes of botulinum toxoid and toxin, is effective in treating symptomatic botulism caused by serotypes A to G neurotoxins. Studies using pharmacokinetic and exposure-response models show that BAT product provides high survival rates and significant protection against clinical signs at various exposure levels.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Exposure-response analysis of Raltitrexed assessing liver toxicity

Bernard Royer, Antonin Schmitt, Thierry Nguyen, Marine Jary, Martin Demarchi, Dewi Vernerey, Julie Henriques, Marion Jacquin, Christophe Borg, Stefano Kim, Marie-Justine Paillard

Summary: The study compared the PK of RTX between every 2 weeks and every 3 weeks administration, finding that creatinine clearance and sex were covariates of RTX clearance, while weight and body surface area were covariates of central and peripheral volumes of distribution. AUC was found to be a good predictor of liver toxicity.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation

Hyokee Kim, Ahram Han, Sanghyun Ahn, Seung-Kee Min, Jongwon Ha, Sangil Min

Summary: This study found that Tacrolimus intra-patient variability (IPV) is associated with long-term kidney transplantation outcomes, and high IPV is associated with CNI nephrotoxicity. Genetic analysis also discovered an association between CYP3A4 polymorphism (rs2837159) and CNI nephrotoxicity.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Oncology

Exposure-Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma

Lora Hamuro, Zheyi Hu, Julie Passarell, Heather Barcomb, Joshua Zhang, Shay Goldstein, Akintunde Bello, Amit Roy, Li Zhu

Summary: A benefit:risk assessment was conducted using modeling and simulation of clinical trial data to evaluate the less-frequent dosing regimen of nivolumab and cabozantinib. The results showed comparable efficacy and safety between different dosing regimens.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Dietary glycyl-glutamine supplementation ameliorates intestinal integrity, inflammatory response, and oxidative status in association with the gut microbiota in LPS-challenged piglets†

Baoyang Xu, Yiqin Yan, Boqi Yin, Le Zhang, Wenxia Qin, Yaorong Niu, Yimei Tang, Shuyi Zhou, Xianghua Yan, Libao Ma

Summary: The study showed that dietary GlyGln supplementation improved the inflammation response induced by LPS and protected the morphology of the ileum. Furthermore, GlyGln enriched the gut microbiota by restoring diversity, promoting obligate anaerobes, and increasing levels of SCFA-producing bacteria, leading to improved gut health and function.

FOOD & FUNCTION (2021)

Add to Collection

Article Urology & Nephrology

Renal Functional Response-Association With Birth Weight and Kidney Volume

Bjorn Steinar Lillas, Camilla Tondel, Toralf Melsom, Bjorn Odvar Eriksen, Hans-Peter Marti, Bjorn Egil Vikse

Summary: This study investigates the relationship among birth weight, kidney volume, and renal functional response (RFR) in middle-aged adults. The results show that larger kidney volume is associated with higher RFR, while higher glomerular filtration rate (GFR) per kidney volume is associated with lower RFR. Birth weight is not associated with RFR.

KIDNEY INTERNATIONAL REPORTS (2023)

Add to Collection

Article Genetics & Heredity

Pathogen exposure misclassification can bias association signals in GWAS of infectious diseases when using population-based common control subjects

Dylan Duchen, Candelaria Vergara, Chloe L. Thio, Prosenjit Kundu, Nilanjan Chatterjee, David L. Thomas, Genevieve L. Wojcik, Priya Duggal

Summary: Genome-wide association studies have been used to identify host genetic factors for various phenotypes, including infectious diseases. The use of population-based common control subjects is a valuable resource to increase sample sizes, but the choice of control subjects is especially important for infectious diseases due to potential selection bias.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Add to Collection

Review Environmental Sciences

Association between exposure to ambient particulate matters and risks of autism spectrum disorder in children: a systematic review and exposure-response meta-analysis

Cheng-Kuan Lin, Yuan-Ting Chang, Fu-Shiuan Lee, Szu-Ta Chen, David Christiani

Summary: The study reviewed the impact of prenatal and early childhood exposure to ambient particulate matters on the risk of autism spectrum disorder in children, finding a positive association between PM2.5 exposure and ASD risk.

ENVIRONMENTAL RESEARCH LETTERS (2021)

Add to Collection

Article Environmental Sciences

Oral cavity response to air pollutant exposure and association with pulmonary inflammation and symptoms in asthmatic children

Linchen He, Christina Norris, Xiaoxing Cui, Zhen Li, Karoline K. Barkjohn, Yanbo Teng, Lin Fang, Lili Lin, Qian Wang, Xiaojian Zhou, Jianguo Hong, Feng Li, Yinping Zhang, James J. Schauer, Marilyn Black, Michael H. Bergin, Junfeng (Jim) Zhang

Summary: Exposure to PM2.5 and O-3 may cause inflammation and oxidative damage in the oral cavity, which could contribute to the worsening of airway inflammation and asthma symptoms. The study found a positive association between PM2.5 exposure and salivary IL-6 concentration, but no clear association between O-3 exposure and salivary biomarkers. Increased salivary IL-6 was related to increased pulmonary inflammation and worsening asthma symptoms. Salivary IL-6 mediated a portion of the association between PM2.5 exposure and FeNO as well as C-ACT scores.

ENVIRONMENTAL RESEARCH (2022)

Add to Collection

Article Environmental Sciences

The association between maternal exposure to outdoor air pollutants, inflammatory response, and birth weight in healthy women

Tai-Ho Hung, Te-Yao Hsu, Tao-Hsin Tung, Ching-Chang Tsai, Chia-Yu Ou, Fen-Fang Chung, Gwo-Hwa Wan

Summary: This study found that exposure to air pollutants during different stages of pregnancy can directly affect fetal birth weight, including PM10, PM2.5, O3, and SO2. Changes in TNF-? concentrations in maternal blood mediate the effects on fetal weight, suggesting that exposure to air pollutants may have both direct and indirect effects on reducing fetal weight.

ENVIRONMENTAL RESEARCH (2021)

Add to Collection

Review Environmental Sciences

The association of arsenic exposure with hypertension and blood pressure: A systematic review and dose-response meta-analysis

Jiaxin Zhao, Ang Li, Yayuan Mei, Quan Zhou, Yanbing Li, Kai Li, Qun Xu

Summary: Chronic arsenic exposure may lead to hypertension, with a significant but not strong association between high arsenic exposure and hypertension. Arsenic is mainly linked to increasing systolic blood pressure in exposed individuals.

ENVIRONMENTAL POLLUTION (2021)

Add to Collection

Article Environmental Sciences

Association of short-term exposure to source-specific PM2.5 with the cardiovascular response during pregnancy in the Shanghai MCPC study

Ranran Luo, Haixia Dai, Yunhui Zhang, Pengpeng Wang, Yuhan Zhou, Jialin Li, Min Zhou, Liping Qiao, Yingge Ma, Shuhui Zhu, Shuangqing Hu, Cheng Huang, Huijing Shi

Summary: This study examined the associations between source-specific PM2.5 exposure and cardiovascular changes in pregnant women. It found that exposure to PM2.5 from residual oil combustion and dust may be potential risk factors for decreased left ventricular systolic function in pregnant women. Further research is needed to confirm these preliminary findings.

SCIENCE OF THE TOTAL ENVIRONMENT (2021)

Add to Collection

Article Medicine, Research & Experimental

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands

Anne Kleijburg, C. Louwrens Braal, Justin D. Westenberg, Agnes Jager, Stijn L. W. Koolen, Ron H. J. Mathijssen, Carin A. Uyl-de Groot, Pim Wetzelaer, Hannah Penton

Summary: The study aimed to describe health-related quality of life (HRQoL) and productivity in Dutch breast cancer patients treated with tamoxifen in an adjuvant setting. HRQoL was measured using the EQ-5D-5L and FACT-B questionnaire, and productivity using the iMTA Productivity Costs Questionnaire. The results showed no differences in HRQoL scores between 3 months and 6 months after tamoxifen initiation, but age and employment status were associated with lower FACT-B scores. Short-term and long-term productivity improved during the first six months of tamoxifen treatment. These findings provide valuable information for health economic evaluations and decision making for breast cancer patients.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort Study

Daan C. H. van Dorst, Sumeyye Kabadayi, Esther Oomen-de Hoop, A. H. Jan Danser, Ron H. J. Mathijssen, Jorie Versmissen

Summary: VEGFI treatment leads to a rise in blood pressure in about 47% of patients, with calcium channel blockers and renin-angiotensin system inhibitors being effective in lowering blood pressure. Risk factors for BP rise include pazopanib therapy and estimated glomerular filtration rate <60 mL/min per 1.73 m², while high baseline BP is associated with a lower risk. BP rise is associated with improved overall survival in renal cell carcinoma patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Add to Collection

Article Oncology

The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer

S. M. Buijs, E. Oomen-de Hoop, C. L. Braal, M. M. van Rosmalen, J. C. Drooger, Q. C. van Rossum-Schornagel, M. B. Vastbinder, S. L. W. Koolen, A. Jager, R. H. J. Mathijssen

Summary: This study found that dose reduction of tamoxifen based on endoxifen levels can decrease its side-effects and improve patients' quality of life.

ESMO OPEN (2023)

Add to Collection

Article Medicine, Research & Experimental

Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases

Nikki S. IJzerman, Wills F. Filipe, Peter de Bruijn, Florian E. Buisman, Leni van Doorn, Pascal G. Doornebosch, Jessica J. Holster, Cecile Grootscholten, Dirk J. Gruenhagen, Christian P. E. van Bommel, Marjolein Y. V. Homs, Niels F. M. Kok, Cornelis Verhoef, Bas Groot Koerkamp, Koert F. D. Kuhlmann, Ron H. J. Mathijssen, Stijn L. W. Koolen

Summary: This study aimed to quantify the systemic exposure of floxuridine and found that most patients had low concentrations of floxuridine, which decreased over time, indicating minimal systemic side-effects.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Article Medicine, Research & Experimental

Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD

Mirjam de With, Leni van Doorn, Demi C. Maasland, Tessa A. M. Mulder, Esther Oomen-de Hoop, Bianca Mostert, Marjolein Y. V. Homs, Samira El Bouazzaoui, Ron H. J. Mathijssen, Ron H. N. van Schaik, Sander Bins

Summary: This study investigated whether single nucleotide polymorphisms (SNPs) in genes involved in capecitabine metabolism other than DPYD are associated with an increased risk for capecitabine-induced hand-foot syndrome (HFS). The results showed that carriers of the CES1 1165-33 C>A (rs2244613) and CDA 266 + 242 A>G (rs10916825) variant alleles have a higher risk of HFS grade 2.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Article Oncology

Influence of Food With Different Fat Concentrations on Alectinib Exposure : A Randomized Crossover Pharmacokinetic Trial

Daan A. C. Lanser, Simon P. de Leeuw, Esther Oomen-de Hoop, Peter de Bruijn, Marthe S. Paats, Daphne W. Dumoulin, Stijn L. W. Koolen, Anne -Marie C. Dingemans, Ron H. J. Mathijssen, Marijn Veerman

Summary: This study investigated the influence of different diets on the exposure of alectinib in ALK+ NSCLC patients. The results showed that low-fat yogurt significantly reduced the exposure of alectinib compared to other diets, while a self-chosen lunch did not change the exposure. Therefore, patients and physicians should be cautious about the food-drug interaction between alectinib and low-fat yogurt, as it may lead to reduced exposure.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2023)

Add to Collection

Article Oncology

Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer

Simon P. de Leeuw, Melinda A. Pruis, Barend J. Sikkema, Mostafa Mohseni, G. D. Marijn Veerman, Marthe S. Paats, Daphne W. Dumoulin, Egbert F. Smit, Annemie M. W. J. Schols, Ron H. J. Mathijssen, Elisabeth F. C. van Rossum, Anne-Marie C. Dingemans

Summary: Alectinib, a standard treatment for metastatic ALK+ NSCLC, can lead to weight gain in approximately 10% of patients. This study analyzed body composition changes in patients treated with alectinib and found increases in waist circumference, visceral adipose tissue, subcutaneous adipose tissue, and skeletal muscle. Furthermore, in-depth analysis of four patients with significant weight gain revealed increased appetite and metabolic syndrome. These findings suggest that alectinib can cause abdominal obesity and various metabolic, physical, and mental disturbances.

JOURNAL OF THORACIC ONCOLOGY (2023)

Add to Collection

Article Oncology

mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer

Khrystany T. Isebia, Bianca Mostert, Teoman Deger, Jaco Kraan, Vanja de Weerd, Esther Oomen-de Hoop, Paul Hamberg, Brigitte C. M. Haberkorn, Helgi H. Helgason, Ronald de Wit, Ron H. J. Mathijssen, Martijn P. Lolkema, Saskia M. Wilting, Job van Riet, John W. M. Martens

Summary: In this study, the researchers found that the abnormal aneuploidy score of cell-free tumor DNA (ctDNA) in the blood can predict the survival of metastatic castration-resistant prostate cancer (mCRPC) patients, making it a potential biomarker.

MOLECULAR ONCOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

G. D. Marijn Veerman, Rene J. Boosman, Esther Oomen-de Hoop, Anthonie J. van der Wekken, Idris Bahce, Lizza E. L. Hendriks, Sander Croes, Christi M. J. Steendam, Evert de Jonge, Stijn L. W. Koolen, Neeltje Steeghs, Ron H. N. van Schaik, Egbert F. Smit, Anne-Marie C. Dingemans, Alwin D. R. Huitema, Ron H. J. Mathijssen

Summary: This study investigated the relationship between single nucleotide polymorphisms (SNPs) and the central nervous system (CNS) treatment efficacy of osimertinib in patients with EGFRm+ non-small cell lung cancer. The results showed that ABCG2 34G>A and ABCB1 3435C>T were predictors for developing new CNS metastases during osimertinib treatment. ABCG2 421C>A was significantly related to the incidence of severe toxicity.

ECLINICALMEDICINE (2023)

Add to Collection

Article Medicine, Research & Experimental

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients

Daan A. C. Lanser, Maud B. A. Van der Kleij, G. D. Marijn Veerman, Neeltje Steeghs, Alwin D. R. Huitema, Ron H. J. Mathijssen, Esther Oomen-de Hoop

Summary: Polypharmacy is increasing in society, which poses greater risks of drug-drug interactions for patients. This is particularly concerning in oncology due to the prevalence of neoplasms with age and polypharmacy. In addition to drug-drug interactions, herb-drug and food-drug interactions may also occur. Understanding these interactions is crucial for safe and effective anti-cancer treatment. A cross-over pharmacokinetic study is commonly used to study interaction effects, but various factors need to be considered. This article provides an overview of these factors and discusses their impact.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Review Pharmacology & Pharmacy

Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology

Maud B. A. van der Kleij, Niels A. D. Guchelaar, Ron H. J. Mathijssen, Jurjen Versluis, Alwin D. R. Huitema, Stijn L. W. Koolen, Neeltje Steeghs

Summary: Although there is large interpatient variability with kinase inhibitors (KI), a 'one size fits all' regimen is still often used. However, dose adjustments based on therapeutic drug monitoring (TDM) using measured systemic pharmacokinetic levels could improve treatment efficacy and reduce toxicities. This comprehensive review provides an overview of the evidence for TDM in patients using 77 FDA/EMA-approved KIs in hematology and oncology, including exposure-response and exposure-toxicity relationships and practical recommendations for TDM.

CLINICAL PHARMACOKINETICS (2023)

Add to Collection

Article Pharmacology & Pharmacy

Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1

Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J. de Neijs, Esther de Hoop, Esther van Meerten, Ron H. N. van Schaik, Ron H. J. Mathijssen, Sander Bins

Summary: In this study, the correlation between genetic polymorphisms in genes involved in irinotecan metabolism and transport and irinotecan-related toxicity was investigated. The study found that SNPs in ABCG2 and CES1 may serve as predictive markers for irinotecan-induced toxicity.

CLINICAL PHARMACOKINETICS (2023)

Add to Collection

Letter Oncology

Reply To the Letter to the Editor by Fruge et al

Daan A. C. Lanser, Anne-Marie C. Dingemans, Ron H. J. Mathijssen, G. D. Marijn Veerman

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2023)

Add to Collection

Letter Oncology

Approach to Alectinib- Induced Body Weight Gain in Patients With ALK plus Non-Small Lung Cancer

Anne-Marie C. Dingemans, Ron H. J. Mathijssen, Elisabeth F. C. van Rossum

JOURNAL OF THORACIC ONCOLOGY (2023)

Add to Collection

Article Oncology

CBD-oil as a potential solution in case of severe tamoxifen-related side effects

Sanne M. Buijs, C. Louwrens Braal, Stefan A. J. Buck, Noud F. van Maanen, Lonneke M. van der Meijden-erkelens, Heleen A. Kuijper-Tissot van Patot, Esther Oomen-de Hoop, Lotte Saes, Sophia J. van den Boogerd, Liesbeth E. M. Struik, Quirine C. van Rossum-Schornagel, Ron H. J. Mathijssen, Stijn L. W. Koolen, Agnes Jager

Summary: CBD oil can affect the pharmacokinetics of tamoxifen through CYP2D6 inhibition, but it has beneficial effects on tamoxifen-related side effects and can improve patients' quality of life.

NPJ BREAST CANCER (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.